Z-1376-04
ProSpecT Cryptosporidium Microplate Assay. Catalog #2454096
Remel Inc / initiated 2002-05-09 / Terminated
Remel, Inc. began a recall of ProSpecT Cryptosporidium Microplate Assay. Catalog #2454096 on . The reason FDA records is "A potential stability problem has been identified with the Positive Controls in the referenced kit lots of the ProSpecT Cryptosporidium Microplate Assay. The Positive Control may NOT perform as intended through its...". As of , the recall status on record is Terminated.
Recall record
- Recall number
- Z-1376-04
- Status
- Terminated
- Initiated
- Posted
- Terminated
- Recalling firm
- Remel Inc
- Product
- ProSpecT Cryptosporidium Microplate Assay. Catalog #2454096.
- Product code
- MHJ Cryptosporidium Spp.
- Reason for recall
- A potential stability problem has been identified with the Positive Controls in the referenced kit lots of the ProSpecT Cryptosporidium Microplate Assay. The Positive Control may NOT perform as intended through its expiration date and may invalidate an otherwise acceptable run. Quality control testing indicates the other reagents in these kits are performing as intended.
- FDA root cause
- Other
- Action
- A potential stability problem has been identified with the positive control in the ProSpecT CryptoSporidium Microplate Assay. The positive control may not perform as intended through its expiration date and may invalidate an otherwise acceptable run.
- Quantity in commerce
- 388 kits (187 - 910717, 201 - 912101)
- Distribution
- in the US
- Product codes and lots
- 910717 912101
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
